AU2008214202A1 - Stabilized picoplatin oral dosage form - Google Patents

Stabilized picoplatin oral dosage form Download PDF

Info

Publication number
AU2008214202A1
AU2008214202A1 AU2008214202A AU2008214202A AU2008214202A1 AU 2008214202 A1 AU2008214202 A1 AU 2008214202A1 AU 2008214202 A AU2008214202 A AU 2008214202A AU 2008214202 A AU2008214202 A AU 2008214202A AU 2008214202 A1 AU2008214202 A1 AU 2008214202A1
Authority
AU
Australia
Prior art keywords
picoplatin
dosage form
oral dosage
coating
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008214202A
Other languages
English (en)
Inventor
Christen M. Giandomenico
Alistair J. Leigh
Christopher A. Procyshyn
Ernest S. Y. Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Poniard Pharmaceuticals Inc
Original Assignee
Genzyme Corp
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Poniard Pharmaceuticals Inc filed Critical Genzyme Corp
Publication of AU2008214202A1 publication Critical patent/AU2008214202A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2008214202A 2007-02-09 2008-02-08 Stabilized picoplatin oral dosage form Abandoned AU2008214202A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US88917107P 2007-02-09 2007-02-09
US60/889,171 2007-02-09
US88968107P 2007-02-13 2007-02-13
US60/889,681 2007-02-13
PCT/US2008/001752 WO2008097661A1 (en) 2007-02-09 2008-02-08 Stabilized picoplatin oral dosage form

Publications (1)

Publication Number Publication Date
AU2008214202A1 true AU2008214202A1 (en) 2008-08-14

Family

ID=39682046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008214202A Abandoned AU2008214202A1 (en) 2007-02-09 2008-02-08 Stabilized picoplatin oral dosage form

Country Status (12)

Country Link
EP (1) EP2114418A4 (https=)
JP (1) JP2010518089A (https=)
KR (1) KR20090109129A (https=)
CN (2) CN101678046A (https=)
AU (1) AU2008214202A1 (https=)
BR (1) BRPI0806418A2 (https=)
CA (1) CA2677640A1 (https=)
HK (1) HK1206267A1 (https=)
IL (1) IL200262A0 (https=)
MX (1) MX2009008488A (https=)
RU (1) RU2009133446A (https=)
WO (1) WO2008097661A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
EP2418955A4 (en) * 2009-04-15 2012-11-21 Poniard Pharmaceuticals Inc ORAL PICOPLATIN ANTITUMOR THERAPY WITH HIGH BIOAVAILABILITY
KR102451223B1 (ko) * 2014-05-23 2022-10-05 밍사이트 파마슈티칼스, 인크. 자가면역 질환의 치료
CN107778331B (zh) * 2016-08-27 2020-06-30 鲁南制药集团股份有限公司 一种甲啶铂的提纯方法
CN108864177B (zh) * 2018-04-20 2020-07-28 公安部物证鉴定中心 [2h3]-1-甲氨基-2-苯基丙烷的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
ATE348617T1 (de) * 2000-02-16 2007-01-15 Astellas Pharma Inc Heilmittel gegen durch endothelin verursachte erkrankungen
US6989156B2 (en) * 2001-04-23 2006-01-24 Nucryst Pharmaceuticals Corp. Therapeutic treatments using the direct application of antimicrobial metal compositions
DE10141528B4 (de) * 2001-08-24 2006-08-10 Faustus Forschungs Cie. Translational Cancer Research Gmbh Platin(II)- und Platin(IV)-Komplexe und ihre Verwendung
US20050119238A1 (en) * 2002-03-01 2005-06-02 Baron John A. Compositions and methods for preventing sporadic neoplasia in colon
WO2004006859A2 (en) * 2002-07-16 2004-01-22 Sonus Pharmaceuticals, Inc. Platinum compound
JP2006502233A (ja) * 2002-08-02 2006-01-19 トランセーブ，インク． 白金凝集物およびその製造方法
WO2005089448A2 (en) * 2004-03-18 2005-09-29 Transave, Inc. Administration of cisplatin by inhalation
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Also Published As

Publication number Publication date
CN104288119A (zh) 2015-01-21
CN101678046A (zh) 2010-03-24
RU2009133446A (ru) 2011-03-20
MX2009008488A (es) 2010-01-15
BRPI0806418A2 (pt) 2011-09-06
CA2677640A1 (en) 2008-08-14
IL200262A0 (en) 2010-04-29
JP2010518089A (ja) 2010-05-27
EP2114418A1 (en) 2009-11-11
WO2008097661A1 (en) 2008-08-14
KR20090109129A (ko) 2009-10-19
HK1206267A1 (en) 2016-01-08
EP2114418A4 (en) 2013-01-09

Similar Documents

Publication Publication Date Title
US20150196494A1 (en) Stabilized picoplatin oral dosage form
ES2410812T5 (es) Preparación de liberación controlada
HK1206267A1 (en) Stabilized picoplatin oral dosage form
US20100062056A1 (en) Encapsulated picoplatin
JPH09511767A (ja) 新規な経口用の医薬使用形態
EP0616802A1 (en) Oral preparation for release in lower digestive tracts
TW202031249A (zh) 緩瀉用錠劑
KR101503559B1 (ko) 경구 분립상 항종양제
RU2343913C2 (ru) Фармацевтическая композиция, содержащая комплекс платины в качестве активного вещества, и способ ее получения
ES2298262T3 (es) Estabilizacion de formulaciones de farmacos tiroideos solidas.
JP2010001242A (ja) レバミピド固形製剤及びその製造方法
JP3122478B2 (ja) 下部消化管放出型経口製剤
US20120148661A1 (en) High bioavailability oral picoplatin anti-cancer therapy
JP3592723B2 (ja) 非崩壊・持続性カプセル製剤
HK1140131A (en) Stabilized picoplatin oral dosage form
JPH06239756A (ja) 制酸剤組成物
Deepika et al. Formulation and Evaluation of Miglitol matrix tablets by using Hibiscus rosa sinensis leaves Mucilage
JP2001288117A (ja) 医薬製剤用組成物
CN113057949A (zh) 一种头孢拉定胶囊及其制备方法
JP2007284394A (ja) 被覆固形製剤

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application